Oragenics Inc  

(Public, NYSEMKT:OGEN)   Watch this stock  
Find more results for OTC:ORNI
-0.030 (-5.00%)
May 27 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 0.50 - 0.62
52 week 0.50 - 3.87
Open 0.60
Vol / Avg. 18,269.00/36,376.00
Mkt cap 21.69M
P/E     -
Div/yield     -
EPS -0.34
Shares 40.06M
Beta 0.98
Inst. own 46%
Mar 30, 2016
Q4 2015 Oragenics Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -786.58% -996.00%
Operating margin -786.83% -990.96%
EBITD margin - -984.91%
Return on average assets -169.98% -138.51%
Return on average equity -217.60% -155.45%
Employees 12 -
CDP Score - -


Suite 125, 4902 Eisenhower Blvd
TAMPA, FL 33634
United States - Map
+1-813-2867900 (Phone)
+1-813-2867904 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Oragenics, Inc. is a biopharmaceutical company. The Company develops, markets and sells oral cavity probiotics products for humans and pets, under the brand names Evora and ProBiora. The Company is developing its antibiotic product candidate, MU1140, as well as other homolog antibiotic product candidates, researching Live Biotherapeutic Products (LBPs), commercializing its ProBiora3 probiotic products and has other product candidates, including SMaRT Replacement Therapy positioned for out licensing or partnering. MU1140 is an antibiotic that is active against all Gram positive bacteria. ProBiora3 is a blend of three naturally occurring strains of beneficial bacteria, including Streptococcus oralis KJ3, Streptococcus uberis KJ2 and Streptococcus rattus JH145, which promotes fresher breath, whiter teeth and supports overall oral health. LPT3-04 is a natural occurring dietary substance that supports weight loss in overweight men and women.

Officers and directors

Frederick W. Telling Ph.D. Independent Chairman of the Board
Age: 63
Bio & Compensation  - Reuters
Michael O'Keefe Sullivan CPA Interim Principal Executive Officer, Chief Financial Officer, Treasurer, Secretary
Age: 58
Bio & Compensation  - Reuters
Alan William Dunton M.D. Independent Director
Age: 61
Bio & Compensation  - Reuters
Christine L. Koski Independent Director
Age: 58
Bio & Compensation  - Reuters
Robert C Koski Independent Director
Age: 56
Bio & Compensation  - Reuters
Charles L. Pope CPA Independent Director
Age: 63
Bio & Compensation  - Reuters